Global Hematology Testing Market Analysis and Forecast, 2019-2029
DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Hematology Testing Market: Focus on Product Type, End-User, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpgResearch and Markets Logo
The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $8.20 billion by 2029.
The ability of a hematology test to effectively measure several blood components has made it an essential screening tool to diagnose a wide range of blood-related disorders, including anemia, blood cancer, hemorrhagic conditions, and blood infections, among others that affect millions of people each year across all age groups. Increasing incidences of hematology disorders and growing awareness related to the availability of a wide range of diagnostic options to treat these targeted disorders are the primary factors driving the growth of the hematology testing market.
Automation, being the primary focus of the hematology testing, the market has been witnessing considerable technological advancements with respect to products that offer effective, accurate, and fast testing results. The availability of automated hematology analyzers has further led to a reduced administrative error, making the process more effective and efficient in disease diagnosis, as compared to manual hematology testing.
The market also witnesses a paradigm shift toward patient-self-testing that eliminates the requirement to travel to a lab, clinic or physicians' office for having the tests done. With the emergence of high throughput hematology analyzers and point-of-care devices, more companies are expected to enter into the market, investing more in its research and development with an effort to develop cost-effective and advanced hematology systems.
Key Questions Answered in this Report:
-- What is the importance of hematology testing and what are the products
involved in hematology testing?
-- What are the key trends of the global hematology testing market? How is
the market evolving and what is its future scope?
-- What are the major drivers, challenges, and opportunities of the global
hematology testing market?
-- What are the key developmental strategies implemented by the key players
of the global hematology testing market to sustain the competition of
the market? What is the percentage share of each of the key players in
different key developmental strategies?
-- Which are the key companies offering hematology products in the market
or have their products in the pipeline? Which are the leading companies
dominating the global hematology testing market? What was the market
share of each of the key players of the global hematology testing market
in 2017 and 2018?
-- What is the regulatory scenario of the global hematology testing market?
What are the initiatives implemented by different governmental bodies
and guidelines put forward to regulate the commercialization of
hematology testing products?
-- What was the market size of the global hematology testing market in 2018
and what is the market size anticipated to be in 2029? What is the
expected growth rate of the global hematology testing market during the
time period between 2019 and 2029?
-- What are the different instruments and consumables involved in
hematology testing? Which instrument type and consumable dominate the
market in 2018 and why? Which instrument and consumable are expected to
witness the highest growth rate and to dominate in market in 2029?
-- What are the different end-users of the global hematology testing
market? Which end-user type dominates the market in 2018 and is expected
to dominate in 2029?
-- What was the market value of the leading segments and sub-segments of
the global hematology testing market? What are the different macro and
micro factors influencing the growth of the market?
-- How is the industry expected to evolve during the forecast period
2019-2029? How is each segment of the global hematology market expected
to grow during the forecast period, and what is the revenue expected to
be generated by each of the segments by the end of 2029?
-- Which region is expected to contribute to the highest sales of the
global hematology testing market during the time period between 2018 and
2029? Which region and country carries the potential for the significant
expansion of key companies for different hematology testing products?
What are the leading countries of different regions that contribute
significantly toward the growth of the hematology testing market?
-- What are the key players of the global hematology testing market and
what is their role in the market?
Companies Mentioned
-- Abbott Laboratories
-- Agilent Technologies, Inc.
-- Bio-Rad Laboratories, Inc.
-- Boule Diagnostics AB
-- Danaher Corporation
-- Drew Scientific Inc.
-- EKF Diagnostics Holdings plc
-- F. Hoffmann-La Roche Ltd
-- HORIBA, Ltd.
-- Mindray Medical International Limited
-- Nihon Kohden Corporation
-- Siemens Healthineers AG
-- Sysmex Corporation
-- Thermo Fisher Scientific Inc.
-- Transasia Bio-Medicals Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/5g7uhk
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-hematology-testing-market-analysis-and-forecast-2019-2029-300971295.html
SOURCE Research and Markets
